• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Thrombosis and Coagulopathy in COVID-19 Patients Requiring Extracorporeal Membrane Oxygenation.

作者信息

Yusuff Hakeem, Zochios Vasileios, Brodie Daniel

机构信息

From the Department of Cardiothoracic Critical Care Medicine and ECMO, University Hospitals of Leicester National Health Service Trust, Glenfield Hospital, Leicester, United Kingdom.

Leicester Medical School, University of Leicester, Leicester, United Kingdom.

出版信息

ASAIO J. 2020 Aug;66(8):844-846. doi: 10.1097/MAT.0000000000001208.

DOI:10.1097/MAT.0000000000001208
PMID:32740341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7268818/
Abstract
摘要

相似文献

1
Thrombosis and Coagulopathy in COVID-19 Patients Requiring Extracorporeal Membrane Oxygenation.需要体外膜肺氧合的COVID-19患者的血栓形成与凝血障碍
ASAIO J. 2020 Aug;66(8):844-846. doi: 10.1097/MAT.0000000000001208.
2
Specific Considerations for Venovenous Extracorporeal Membrane Oxygenation During Coronavirus Disease 2019 Pandemic.COVID-19 大流行期间静脉-静脉体外膜肺氧合的特殊注意事项。
ASAIO J. 2020 Nov/Dec;66(10):1069-1072. doi: 10.1097/MAT.0000000000001251.
3
Delivering extracorporeal membrane oxygenation for patients with COVID-19: what, who, when and how?为新型冠状病毒肺炎患者提供体外膜肺氧合治疗：是什么、谁来做、何时做以及如何做？
Anaesthesia. 2020 Aug;75(8):997-1001. doi: 10.1111/anae.15099. Epub 2020 May 2.
4
Implementation of veno-venous extracorporeal membrane oxygenation in a COVID-19 convalescent.在一名新冠康复者中实施静脉-静脉体外膜肺氧合。
Anaesthesiol Intensive Ther. 2020;52(3):253-255. doi: 10.5114/ait.2020.97956.
5
Veno-Arterial-Venous Extracorporeal Membrane Oxygenation in a Critically Ill Patient with Coronavirus Disease 2019.COVID-19 危重症患者的静脉-动脉-静脉体外膜肺氧合。
Medicina (Kaunas). 2020 Sep 30;56(10):510. doi: 10.3390/medicina56100510.
6
Clinical feedback from experience with COVID-19: Specific considerations for extracorporeal membrane oxygenation.COVID-19临床经验反馈：体外膜肺氧合的特殊考量
J Infect. 2020 Sep;81(3):e59-e60. doi: 10.1016/j.jinf.2020.06.050. Epub 2020 Jun 21.
7
Approaching COVID-19-Bedside strategies for intensive care.应对新冠疫情——重症监护的床边策略
Eur J Clin Invest. 2020 Jul;50(7):e13310. doi: 10.1111/eci.13310. Epub 2020 Jun 29.
8
Optimal therapeutic strategy using extracorporeal membrane oxygenation in patients with COVID-19.新型冠状病毒肺炎患者使用体外膜肺氧合的最佳治疗策略
J Card Surg. 2020 Oct;35(10):2872-2873. doi: 10.1111/jocs.14831.
9
Extracorporeal Membrane Oxygenation for Critically Ill Patients with COVID-19-related Acute Respiratory Distress Syndrome: Worth the Effort?体外膜肺氧合用于治疗新型冠状病毒肺炎相关急性呼吸窘迫综合征的重症患者：值得一试吗？
Am J Respir Crit Care Med. 2020 Aug 1;202(3):460-463. doi: 10.1164/rccm.202004-1370LE.
10
Venous Thromboembolism Events Following Venovenous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Syndrome Coronavirus 2 Based on CT Scans.基于 CT 扫描的静脉-静脉体外膜肺氧合治疗严重急性呼吸综合征冠状病毒 2 后静脉血栓栓塞事件。
Crit Care Med. 2020 Oct;48(10):e971-e975. doi: 10.1097/CCM.0000000000004504.

引用本文的文献

1
Activated Partial Thromboplastin Time and Anti-IIa Monitoring in Argatroban Anticoagulation in COVID-19 Patients on Venovenous Extracorporeal Membrane Oxygenation.新冠病毒肺炎患者接受静脉-静脉体外膜肺氧合治疗时使用阿加曲班抗凝的活化部分凝血活酶时间及抗IIa监测
Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296251341315. doi: 10.1177/10760296251341315. Epub 2025 May 21.
2
The Use of Extracorporeal Membrane Oxygenation for COVID-19: Lessons Learned.体外膜肺氧合在 COVID-19 中的应用：经验教训。
Clin Chest Med. 2023 Jun;44(2):335-346. doi: 10.1016/j.ccm.2022.11.016. Epub 2022 Nov 29.
3
Thrombotic Events Develop in 1 Out of 5 Patients Receiving ECMO Support: An 11-Year Referral Centre Experience.接受体外膜肺氧合支持的患者中，每5人就有1人发生血栓事件：一家转诊中心11年的经验。
J Clin Med. 2023 Jan 30;12(3):1082. doi: 10.3390/jcm12031082.
4
Outcomes of Extracorporeal Membrane Oxygenation (ECMO) for COVID-19 Patients: A Multi-Institutional Analysis.新型冠状病毒肺炎患者体外膜肺氧合治疗的结果：一项多机构分析
Vaccines (Basel). 2023 Jan 1;11(1):108. doi: 10.3390/vaccines11010108.
5
A fibrin enhanced thrombosis model for medical devices operating at low shear regimes or large surface areas.用于在低切变区或大面积工作的医疗器械的纤维蛋白增强血栓形成模型。
PLoS Comput Biol. 2022 Oct 3;18(10):e1010277. doi: 10.1371/journal.pcbi.1010277. eCollection 2022 Oct.
6
Coagulopathy during COVID-19 infection: a brief review.COVID-19 感染期间的凝血功能障碍：简要综述。
Clin Exp Med. 2023 Jul;23(3):655-666. doi: 10.1007/s10238-022-00891-4. Epub 2022 Sep 19.
7
Variation in outcomes with extracorporeal membrane oxygenation in the era of coronavirus: A multicenter cohort evaluation.体外膜肺氧合在冠状病毒时代的结局变化：一项多中心队列评估。
Perfusion. 2023 Oct;38(7):1501-1510. doi: 10.1177/02676591221118321. Epub 2022 Aug 9.
8
Overt Disseminated Intravascular Coagulation with Severe Hypofibrinogenemia During Veno-Venous Extracorporeal Membrane Oxygenation.体外膜肺氧合期间伴严重低纤维蛋白原血症的显性弥漫性血管内凝血。
J Extra Corpor Technol. 2022 Jun;54(2):148-152. doi: 10.1182/ject-148-152.
9
Dynamic blood oxygen indices in mechanically ventilated COVID-19 patients with acute hypoxic respiratory failure: A cohort study.机械通气 COVID-19 急性低氧性呼吸衰竭患者的动态血氧指标：一项队列研究。
PLoS One. 2022 Jun 10;17(6):e0269471. doi: 10.1371/journal.pone.0269471. eCollection 2022.
10
Thrombosis and coagulopathy in COVID-19 patients rceiving ECMO: A narrative review of current literature.新冠肺炎患者接受体外膜肺氧合治疗后发生的血栓与凝血障碍：对当前文献的叙述性综述。
J Cardiothorac Vasc Anesth. 2022 Aug;36(8 Pt B):3312-3317. doi: 10.1053/j.jvca.2022.03.032. Epub 2022 Mar 31.

本文引用的文献

1
Extracorporeal membrane oxygenation for COVID-19-associated severe acute respiratory distress syndrome and risk of thrombosis.用于治疗新型冠状病毒肺炎相关严重急性呼吸窘迫综合征的体外膜肺氧合及血栓形成风险
Br J Anaesth. 2020 Aug;125(2):e260-e262. doi: 10.1016/j.bja.2020.04.079. Epub 2020 May 4.
2
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.严重严重急性呼吸综合征冠状病毒 2 型感染患者的血栓形成风险高：一项多中心前瞻性队列研究。
Intensive Care Med. 2020 Jun;46(6):1089-1098. doi: 10.1007/s00134-020-06062-x. Epub 2020 May 4.
3
Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction.对新冠病毒疾病（COVID-19）患者的尸检显示，肺部出现弥漫性肺泡损伤，伴有严重的毛细血管充血，肺部及其他器官呈现出多样化的表现，提示存在血管功能障碍。
Histopathology. 2020 Aug;77(2):198-209. doi: 10.1111/his.14134. Epub 2020 Jul 5.
4
COVID-19 and its implications for thrombosis and anticoagulation.新型冠状病毒肺炎及其对血栓形成和抗凝的影响。
Blood. 2020 Jun 4;135(23):2033-2040. doi: 10.1182/blood.2020006000.
5
Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands.新型冠状病毒肺炎相关血栓栓塞性并发症的诊断、预防和治疗：荷兰国家公共卫生研究所报告。
Radiology. 2020 Oct;297(1):E216-E222. doi: 10.1148/radiol.2020201629. Epub 2020 Apr 23.
6
Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series.中国危重症新冠肺炎患者使用体外膜肺氧合（ECMO）治疗的预后：一项回顾性病例系列研究。
Crit Care. 2020 Apr 15;24(1):148. doi: 10.1186/s13054-020-2840-8.
7
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
8
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations.2019 冠状病毒病（COVID-19）的重症监护管理：挑战与建议。
Lancet Respir Med. 2020 May;8(5):506-517. doi: 10.1016/S2213-2600(20)30161-2. Epub 2020 Apr 6.
9
Initial ELSO Guidance Document: ECMO for COVID-19 Patients with Severe Cardiopulmonary Failure.最初的体外生命支持组织（ELSO）指导文件：用于患有严重心肺衰竭的COVID-19患者的体外膜肺氧合（ECMO）
ASAIO J. 2020 May;66(5):472-474. doi: 10.1097/MAT.0000000000001173.
10
Multi-Modal Characterization of the Coagulopathy Associated With Extracorporeal Membrane Oxygenation.体外膜肺氧合相关凝血功能障碍的多模态特征分析。
Crit Care Med. 2020 May;48(5):e400-e408. doi: 10.1097/CCM.0000000000004286.